Suministro de Insulinas Año 2018 para el Hrlbo
El Hospital Regional Libertador Bernardo O´Higgins en adelante el Hospital llama a licitación pública para la “ADQUISICION DE SUMINISTRO DE INSULINAS AÑO 2018 PARA EL HOSPITAL LIBERTADOR BERNARDO O`HIGGINS”, con la finalidad de apoyar la actividad de apoy
3 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2080-1713-SE19 | 13-02-2019 | Novo Nordisk Farmaceutica Limitada | $2.142.000 |
| 2080-1318-SE19 | 05-02-2019 | Novo Nordisk Farmaceutica Limitada | $1.115.982 |
| 2080-1233-SE19 | 01-02-2019 | Novo Nordisk Farmaceutica Limitada | $1.115.982 |
| 2080-1114-SE19 | 30-01-2019 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2080-972-SE19 | 25-01-2019 | Novo Nordisk Farmaceutica Limitada | $123.998 |
| 2080-304-SE19 | 09-01-2019 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2080-209-SE19 | 08-01-2019 | Novo Nordisk Farmaceutica Limitada | $991.984 |
| 2080-208-SE19 | 08-01-2019 | Novo Nordisk Farmaceutica Limitada | $788.256 |
| 2080-13352-SE18 | 31-12-2018 | Aventis Pharma Holding Gmbh | $12.495.000 |
| 2080-13351-SE18 | 31-12-2018 | Aventis Pharma Holding Gmbh | $3.727.080 |
| 2080-12851-SE18 | 12-12-2018 | Aventis Pharma Holding Gmbh | $7.996.800 |
| 2080-12791-SE18 | 11-12-2018 | Novo Nordisk Farmaceutica Limitada | $1.028.160 |
| 2080-12473-SE18 | 03-12-2018 | Aventis Pharma Holding Gmbh | $4.284.000 |
| 2080-12184-SE18 | 27-11-2018 | Aventis Pharma Holding Gmbh | $7.996.800 |
| 2080-11934-SE18 | 22-11-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-11603-SE18 | 12-11-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-11386-SE18 | 09-11-2018 | Aventis Pharma Holding Gmbh | $5.997.600 |
| 2080-11152-SE18 | 05-11-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-11148-SE18 | 05-11-2018 | Novo Nordisk Farmaceutica Limitada | $991.984 |
| 2080-10622-SE18 | 22-10-2018 | Novo Nordisk Farmaceutica Limitada | $788.256 |
| 2080-10553-SE18 | 22-10-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-10558-SE18 | 22-10-2018 | Aventis Pharma Holding Gmbh | $5.997.600 |
| 2080-9890-SE18 | 04-10-2018 | Novo Nordisk Farmaceutica Limitada | $1.780.240 |
| 2080-9891-SE18 | 04-10-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-9892-SE18 | 04-10-2018 | Aventis Pharma Holding Gmbh | $5.997.600 |
| 2080-9299-SE18 | 20-09-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-9298-SE18 | 20-09-2018 | Aventis Pharma Holding Gmbh | $5.997.600 |
| 2080-8898-SE18 | 10-09-2018 | Novo Nordisk Farmaceutica Limitada | $1.172.388 |
| 2080-8896-SE18 | 10-09-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-8575-SE18 | 04-09-2018 | Aventis Pharma Holding Gmbh | $5.997.600 |
| 2080-8381-SE18 | 29-08-2018 | Aventis Pharma Holding Gmbh | $1.285.200 |
| 2080-8344-SE18 | 28-08-2018 | Aventis Pharma Holding Gmbh | $3.998.400 |
| 2080-8080-SE18 | 22-08-2018 | Novo Nordisk Farmaceutica Limitada | $1.048.390 |
| 2080-7862-SE18 | 16-08-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-7656-SE18 | 10-08-2018 | Aventis Pharma Holding Gmbh | $3.998.400 |
| 2080-7175-SE18 | 01-08-2018 | Aventis Pharma Holding Gmbh | $5.712.000 |
| 2080-6862-SE18 | 23-07-2018 | Aventis Pharma Holding Gmbh | $5.712.000 |
| 2080-6692-SE18 | 19-07-2018 | Novo Nordisk Farmaceutica Limitada | $428.400 |
| 2080-6500-SE18 | 13-07-2018 | Novo Nordisk Farmaceutica Limitada | $428.400 |
| 2080-6464-SE18 | 12-07-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-6161-SE18 | 06-07-2018 | Aventis Pharma Holding Gmbh | $3.998.400 |
| 2080-5864-SE18 | 29-06-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-5784-SE18 | 26-06-2018 | Aventis Pharma Holding Gmbh | $4.998.000 |
| 2080-5765-SE18 | 26-06-2018 | Aventis Pharma Holding Gmbh | $556.920 |
| 2080-5424-SE18 | 18-06-2018 | Aventis Pharma Holding Gmbh | $4.998.000 |
| 2080-3857-SE18 | 13-06-2018 | Novo Nordisk Farmaceutica Limitada | $428.400 |
| 2080-5170-SE18 | 11-06-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
| 2080-3858-SE18 | 31-05-2018 | Aventis Pharma Holding Gmbh | $1.713.600 |
Fuente original:ficha mercadopublico.cl
